These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 30368504)

  • 1. Clinical and Neurofunctional Substrates of Cognitive Behavioral Therapy on Secondary Social Anxiety Disorder in Primary Panic Disorder: A Longitudinal fMRI Study.
    Seeger F; Yang Y; Straube B; Kircher T; Höfler M; Wittchen HU; Ströhle A; Wittmann A; Gerlach AL; Pfleiderer B; Arolt V; Hamm A; Lang T; Alpers GW; Fydrich T; Lueken U
    Psychother Psychosom; 2019; 88(1):48-51. PubMed ID: 30368504
    [No Abstract]   [Full Text] [Related]  

  • 2. The impact of depressive comorbidity on neural plasticity following cognitive-behavioral therapy in panic disorder with agoraphobia.
    Kunas SL; Yang Y; Straube B; Kircher T; Gerlach AL; Pfleiderer B; Arolt V; Wittmann A; Stroehle A; Wittchen HU; Lueken U
    J Affect Disord; 2019 Feb; 245():451-460. PubMed ID: 30428445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive-behavioural outreach for an adolescent experiencing social anxiety, panic and agoraphobia: A single-case experimental design.
    Waldron SM; Maddern L; Wynn A
    J Child Adolesc Psychiatr Nurs; 2018 Nov; 31(4):120-126. PubMed ID: 30565788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered top-down and bottom-up processing of fear conditioning in panic disorder with agoraphobia.
    Lueken U; Straube B; Reinhardt I; Maslowski NI; Wittchen HU; Ströhle A; Wittmann A; Pfleiderer B; Konrad C; Ewert A; Uhlmann C; Arolt V; Jansen A; Kircher T
    Psychol Med; 2014 Jan; 44(2):381-94. PubMed ID: 23611156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neural substrates of treatment response to cognitive-behavioral therapy in panic disorder with agoraphobia.
    Lueken U; Straube B; Konrad C; Wittchen HU; Ströhle A; Wittmann A; Pfleiderer B; Uhlmann C; Arolt V; Jansen A; Kircher T
    Am J Psychiatry; 2013 Nov; 170(11):1345-55. PubMed ID: 23982225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of cognitive-behavioral therapy on neural correlates of fear conditioning in panic disorder.
    Kircher T; Arolt V; Jansen A; Pyka M; Reinhardt I; Kellermann T; Konrad C; Lueken U; Gloster AT; Gerlach AL; Ströhle A; Wittmann A; Pfleiderer B; Wittchen HU; Straube B
    Biol Psychiatry; 2013 Jan; 73(1):93-101. PubMed ID: 22921454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What is the effect on comorbid personality disorder of brief panic-focused psychotherapy in patients with panic disorder?
    Keefe JR; Milrod BL; Gallop R; Barber JP; Chambless DL
    Depress Anxiety; 2018 Mar; 35(3):239-247. PubMed ID: 29212135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Social Anxiety and Fear of Causing Discomfort to Others: Diagnostic Specificity, Symptom Correlates and CBT Treatment Outcome.
    Nishikawa Y; Laposa JM; Regev R; Rector NA
    Behav Cogn Psychother; 2017 Jul; 45(4):382-400. PubMed ID: 28260554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticipating agoraphobic situations: the neural correlates of panic disorder with agoraphobia.
    Wittmann A; Schlagenhauf F; Guhn A; Lueken U; Gaehlsdorf C; Stoy M; Bermpohl F; Fydrich T; Pfleiderer B; Bruhn H; Gerlach AL; Kircher T; Straube B; Wittchen HU; Arolt V; Heinz A; Ströhle A
    Psychol Med; 2014 Aug; 44(11):2385-96. PubMed ID: 24398049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Group cognitive-behavioral treatment of panic disorder.
    Telch MJ; Lucas JA; Schmidt NB; Hanna HH; LaNae Jaimez T; Lucas RA
    Behav Res Ther; 1993 Mar; 31(3):279-87. PubMed ID: 8476402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive-behavioral group psychotherapy for agoraphobia and panic disorder.
    Belfer PL; Munoz LS; Schachter J; Levendusky PG
    Int J Group Psychother; 1995 Apr; 45(2):185-206. PubMed ID: 7759179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Learn to forget: Does post-exposure administration of d-cycloserine enhance fear extinction in agoraphobia?
    Pyrkosch L; Mumm J; Alt I; Fehm L; Fydrich T; Plag J; Ströhle A
    J Psychiatr Res; 2018 Oct; 105():153-163. PubMed ID: 30237105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improvement in adult anxious and avoidant attachment during cognitive behavioral therapy for panic disorder.
    Zalaznik D; Weiss M; Huppert JD
    Psychother Res; 2019 Apr; 29(3):337-353. PubMed ID: 28826378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neural correlates of procedural variants in cognitive-behavioral therapy: a randomized, controlled multicenter FMRI study.
    Straube B; Lueken U; Jansen A; Konrad C; Gloster AT; Gerlach AL; Ströhle A; Wittmann A; Pfleiderer B; Gauggel S; Wittchen U; Arolt V; Kircher T
    Psychother Psychosom; 2014; 83(4):222-33. PubMed ID: 24970601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Panic-free status is not associated with improvement on continuous measures in panic disorder.
    van Balkom AJ; Spinhoven P; Bakker A; Rammeloo KC; Graatsma AT; Adriaanse MT; van Dyck R
    J Nerv Ment Dis; 2000 Dec; 188(12):840-2. PubMed ID: 11191586
    [No Abstract]   [Full Text] [Related]  

  • 16. The Unified Protocol for Transdiagnostic Treatment of Emotional Disorders Compared With Diagnosis-Specific Protocols for Anxiety Disorders: A Randomized Clinical Trial.
    Barlow DH; Farchione TJ; Bullis JR; Gallagher MW; Murray-Latin H; Sauer-Zavala S; Bentley KH; Thompson-Hollands J; Conklin LR; Boswell JF; Ametaj A; Carl JR; Boettcher HT; Cassiello-Robbins C
    JAMA Psychiatry; 2017 Sep; 74(9):875-884. PubMed ID: 28768327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of rs7688285 allelic variation coding for GLRB with fear reactivity and exposure-based therapy in patients with panic disorder and agoraphobia.
    Ridderbusch IC; Richter J; Yang Y; Hoefler M; Weber H; Reif A; Hamm A; Pané-Farré CA; Gerlach AL; Stroehle A; Pfleiderer B; Arolt V; Wittchen HU; Gloster A; Lang T; Helbig-Lang S; Fehm L; Pauli P; Kircher T; Lueken U; Straube B
    Eur Neuropsychopharmacol; 2019 Oct; 29(10):1138-1151. PubMed ID: 31444036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive therapy of anxiety disorders.
    Chambless DL; Gillis MM
    J Consult Clin Psychol; 1993 Apr; 61(2):248-60. PubMed ID: 8473578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anxiety disorders and CRP in a population cohort study with 54,326 participants: The LifeLines study.
    Naudé PJW; Roest AM; Stein DJ; de Jonge P; Doornbos B
    World J Biol Psychiatry; 2018 Sep; 19(6):461-470. PubMed ID: 29376460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stress hormone response to the DEX-CRH test and its relation to psychotherapy outcome in panic disorder patients with and without agoraphobia.
    Wichmann S; Bornstein SR; Lorenz T; Petrowski K
    Transl Psychiatry; 2018 Feb; 8(1):37. PubMed ID: 29391399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.